NIOX Group (LON:NIOX) Releases Earnings Results

NIOX Group (LON:NIOX) issued its quarterly earnings data on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.14% and a net margin of 14.37%.

NIOX Group Stock Performance

Shares of NIOX stock opened at GBX 68.40 on Wednesday. NIOX Group has a 52-week low of GBX 53.84 and a 52-week high of GBX 76. The company has a quick ratio of 1.94, a current ratio of 3.81 and a debt-to-equity ratio of 1.36. The stock’s 50-day moving average price is GBX 65.54 and its 200 day moving average price is GBX 61.58. The stock has a market capitalization of £287.87 million, a PE ratio of 41.71 and a beta of 0.92.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.